Loading
Led the Tata Memorial trial that settled a decades-old question, showing that removing neck lymph nodes at the first operation for early oral cancer saves lives.
Anil D'Cruz is a head and neck surgeon who directed Tata Memorial Hospital before moving to Apollo Hospitals, and has served as President of the Union for International Cancer Control. He was principal investigator of the randomised trial of elective versus therapeutic neck dissection in node-negative oral cancer (596 enrolled, 500 analysed), which found 3-year overall survival of 80.0% with elective dissection against 67.5% with watchful waiting (hazard ratio 0.64) and changed guidelines worldwide. His work spans oral cancer surgery, thyroid cancer and cancer control policy for low- and middle-income countries.
| Title | Journal | Year |
|---|---|---|
| Elective versus therapeutic neck dissection in node-negative oral cancer | New England Journal of Medicine | 2015 |
Shares Tata Memorial Centre, Head and neck squamous cell carcinoma.
Shares Tata Memorial Centre, Head and neck squamous cell carcinoma.
Shares Tata Memorial Centre, Head and neck squamous cell carcinoma.
Shares Elective versus therapeutic neck dissection in node-negative oral cancer, Elective vs therapeutic neck dissection in node-negative oral cancer (Tata Memorial), Sentinel lymph node biopsy.
Shares Tata Memorial Centre, Head and neck squamous cell carcinoma.
Shares Tata Memorial Centre, Head and neck squamous cell carcinoma.
Shares Elective versus therapeutic neck dissection in node-negative oral cancer, Elective vs therapeutic neck dissection in node-negative oral cancer (Tata Memorial), Tata Memorial Centre.
Shares Tata Memorial Centre, Head and neck squamous cell carcinoma.